News
-
-
PRESS RELEASE
Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates
Moderna reports Q2 revenue of $0.1B, net loss of $(0.8)B, updates 2025 revenue to $1.5-$2.2B due to shipment timing, improves operating expenses by $400M, reiterates $6B year-end cash balance. FDA approvals for flu vaccine -
-
-
PRESS RELEASE
L'Oréal Rapport Financier Semestriel 2025
-
PRESS RELEASE
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Press release on total number of voting rights and shares as of 31 July 2025 in accordance with French commercial code and Financial Markets Authority regulations -
PRESS RELEASE
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Communiqué de presse : Nombre total de droits de vote et d'actions au 31 juillet 2025 publié conformément aux dispositions du Code de commerce et de l'AMF -
-
-
